The global alpha mannosidosis market size was valued at USD 9.92 billion in 2021 and is poised to grow at a significant CAGR of 17.8% during the forecast period 2022–2028. The market exclusivity granted to items with the orphan medication designation for several years is pharmaceutical corporations' most significant financial incentive. Since, during this time, regulatory bodies cannot...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian